Latest Underwriting Agreement News

EcoGraf’s underwritten share purchase plan raised $3.552 million, well above its $2 million target, after shareholders applied for the full oversubscription. The result gives the company additional funding while leaving the final issue price and dilution to be confirmed.

Flynn Gold has lodged a prospectus for a one-for-three renounceable rights issue priced at 1.5 cents, offering shareholders a heavily discounted entry point alongside free options. The partially underwritten raise is intended to fund Golden Ridge drilling, a maiden Firetower resource estimate and working capital.

Kalgoorlie Gold Mining has opened a fully underwritten 1-for-10 entitlement offer priced at 2 cents a share, targeting about A$1.1 million for exploration and working capital. The offer completes a broader A$3.4 million capital raising, but also increases the company’s share count by up to 10%.

WCM Global Growth has secured full underwriting for its $6.5 million Dividend Reinvestment Plan tied to a fully franked 2.35 cents per share final dividend. The issue price is due on 22 September, with the new shares scheduled for issue eight days later.

Barys Resources is seeking up to A$2.64 million through a 1-for-1 entitlement offer priced at a 41% discount, with most proceeds earmarked for Kazakhstan gold exploration. But only A$800,000 is underwritten, leaving the final funding outcome and potential dilution dependent on shareholder participation.

Kalgoorlie Gold Mining has secured A$2.3 million through a placement and launched a fully underwritten A$1.1 million entitlement offer to fund exploration at its Pinjin Gold Project. The capital will target new drilling at the Lighthorse discovery, where earlier assays included high-grade gold within broader mineralised intervals.

FBR has fully underwritten its A$2.5 million share purchase plan, removing the immediate risk of an unfunded shortfall but adding cash fees and potential option dilution. Alpine Capital can also terminate the arrangement in several circumstances, including a 10% fall in the S&P/ASX 200 Index.

Actinogen Medical has locked in full underwriting for nearly 127 million unlisted options, guaranteeing $4.77 million in fresh funding as it approaches pivotal Alzheimer’s trial results due in November.

Podium Minerals' recent share purchase plan secured $1.56 million, significantly below its $4 million underwritten target, leaving a $2.44 million shortfall to be addressed.

Alterity Therapeutics has arranged an underwriting deal for up to 8.4 million ATHO options, potentially raising A$4.2 million to A$7.96 million ahead of their expiry. The funds aim to support the upcoming Phase 3 trial for ATH434 in Multiple System Atrophy and bolster working capital.

ASX Limited has updated its FY26 final dividend reinvestment plan (DRP) participation rate to 32.93%, increasing the total DRP size to $106.1 million, supported by continued underwriting from Barrenjoey Markets.

Piche Resources completed a $2.53 million entitlement offer, raising $728,324 from shareholders, with the underwriter stepping in to cover a $1.85 million shortfall. New shares and options are set to trade from 31 August 2026.